Hill-Rom (NYSE:HRC) will be issuing its quarterly earnings data before the market opens on Friday, January 26th. Analysts expect the company to announce earnings of $0.79 per share for the quarter. Hill-Rom has set its Q1 guidance at $0.77-0.79 EPS and its FY18 guidance at $4.22-4.30 EPS.

Hill-Rom (NYSE:HRC) last released its quarterly earnings data on Friday, November 3rd. The medical technology company reported $1.32 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.05. The company had revenue of $738.30 million for the quarter, compared to analyst estimates of $731.10 million. Hill-Rom had a return on equity of 20.27% and a net margin of 4.87%. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 earnings per share. On average, analysts expect Hill-Rom to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Hill-Rom (NYSE:HRC) opened at $87.80 on Friday. The firm has a market capitalization of $5,780.00, a price-to-earnings ratio of 44.12, a price-to-earnings-growth ratio of 1.52 and a beta of 1.19. The company has a debt-to-equity ratio of 1.55, a quick ratio of 1.34 and a current ratio of 1.77. Hill-Rom has a 12 month low of $57.18 and a 12 month high of $88.91.

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 29th. Shareholders of record on Friday, December 15th were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.82%. The ex-dividend date was Thursday, December 14th. Hill-Rom’s dividend payout ratio (DPR) is currently 36.18%.

HRC has been the topic of a number of recent research reports. KeyCorp reissued a “buy” rating and set a $89.00 price objective (up previously from $82.00) on shares of Hill-Rom in a research note on Sunday, November 5th. ValuEngine lowered Hill-Rom from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Raymond James Financial raised Hill-Rom from a “market perform” rating to an “outperform” rating and set a $94.00 price objective on the stock in a research note on Wednesday, January 3rd. Zacks Investment Research raised Hill-Rom from a “hold” rating to a “buy” rating and set a $98.00 price objective on the stock in a research note on Monday, January 8th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $92.00 price objective on shares of Hill-Rom in a research note on Wednesday, November 29th. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Hill-Rom has a consensus rating of “Buy” and an average price target of $95.38.

In other news, CEO John J. Greisch sold 125,241 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $82.59, for a total value of $10,343,654.19. Following the transaction, the chief executive officer now owns 280,851 shares of the company’s stock, valued at approximately $23,195,484.09. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO John J. Greisch sold 100,000 shares of the company’s stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $82.82, for a total value of $8,282,000.00. Following the completion of the transaction, the chief executive officer now directly owns 230,851 shares in the company, valued at approximately $19,119,079.82. The disclosure for this sale can be found here. In the last ninety days, insiders sold 226,241 shares of company stock worth $18,708,644. Corporate insiders own 2.20% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Hill-Rom (HRC) Set to Announce Quarterly Earnings on Friday” was first posted by American Banking News and is the property of of American Banking News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.americanbankingnews.com/2018/01/19/hill-rom-hrc-set-to-announce-quarterly-earnings-on-friday.html.

Hill-Rom Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Earnings History for Hill-Rom (NYSE:HRC)

Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.